ImmuPharma plc (AIM:IMM)
3.720
+0.020 (0.54%)
Jun 26, 2026, 4:35 PM GMT
ImmuPharma Employees
ImmuPharma had 7 employees as of December 31, 2025. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-258.24K GBP
Market Cap
23.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Arecor Therapeutics | 33 |
| SkinBioTherapeutics | 41 |
| Sareum Holdings | 5 |
| Aptamer Group | 30 |
| IXICO | 79 |
| Palatin Technologies | 29 |
| Fusion Antibodies | 24 |
| Poolbeg Pharma | 15 |
ImmuPharma News
- 4 weeks ago - ImmuPharma Annual report: H2 2025 - Filings
- 4 weeks ago - ImmuPharma Annual report: H2 2025 - Filings
- 3 months ago - ImmuPharma Transcript: Investor update - Transcripts
- 3 months ago - ImmuPharma Press release: Investor update - Filings
- 3 months ago - ImmuPharma Slides: Investor update - Filings
- 3 months ago - AIM Market Roundup: Tern, T42 IoT, Atlantic Lithium - The Armchair Trader
- 4 months ago - AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West - The Armchair Trader
- 7 months ago - FTSE Flat as Wall Street Gains Fail to Inspire - Investomania